Use the pricing tool you can find this blend for way cheaper!!! Not sure how much you are dosing for your condition, but a standard dose is 250-500 mcg of each 1-2x daily. Even if you went 1 mg of each daily you could still do it for a lot cheaper than $200 per vial.

This is what ChatGPT had to say about these peptides and their suitability to address your condition: I did a literature sweep. Short answer: I found no high-quality human clinical trials that clearly show BPC-157 or TB-500 healing bone marrow edema (BME) in osteonecrosis / microvascular necrosis. What does exist is mostly animal or in vitro work, with hints, but big gaps. Let me walk you through what turned up, the strengths/weaknesses, and what that suggests (i.e. my working inference). What I found: animal / preclinical evidence + limited human anecdotes BPC-157 What exists in animals / preclinical models: 1. In rats, BPC-157 has been tested in femoral head osteonecrosis models, with Raman spectroscopy used to monitor healing, and showed a “healing effect vs controls.” 2. In segmental bone defect models (e.g. in rabbits), BPC-157 improved bone bridging, callus formation, histomorphometry, etc. 3. In a review of its soft-tissue / bone potential, BPC-157 is often cited as having angiogenic, anti-inflammatory, cell migration / fibroblast stimulating effects, all supportive of tissue repair. 4. There is also a rat / rabbit pseudoarthrosis / nonunion model where BPC-157 “healed” or improved bone healing where spontaneous healing was impaired. 5. A newer article (“Emerging Use of BPC-157 in Orthopaedic Sports Medicine”) mentions an anecdotal human use: 7 out of 12 people with chronic knee pain reportedly felt relief after a BPC-157 injection (though that’s pain, not verified imaging of bone marrow edema) and notes that human safety/efficacy data are minimal. Strengths & caveats: - The animal results are somewhat consistent: in environments of bone injury, deprivation, or partial necrosis, BPC-157 tends to push healing more than controls. That’s encouraging, especially when you need angiogenesis + progenitor cell support. - But animal bone, healing contexts, and models of necrosis are far from identical to your human knee with microvascular compromise. - “Healing” in animal studies often is morphological (histology, radiography), not necessarily restoring perfectly microvascular function or eliminating marrow edema in an ischemic (necrotic) environment. - Dosing, delivery route (local vs systemic), kinetics, and side effects are much less constrained / controlled in animals vs humans. - The anecdotal human report is weak: small number, likely uncontrolled, subjective endpoint.

@Derek Pruski for President in 2028!!!! Derek! Derek! Derek!

In my research, I dosed my lab rat 800 mcg of both in the morning. Gives him calm and confident focus all day. When I dosed him with selank at night, it made him very mellow but not drowsy.

$1.50 hotdog and soda with your peptide order